Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Development of REDX05194, a Novel, Potent and Selective Inhibitor of Bruton's Tyrosine Kinase (BTK) As a Potential Treatment for B-Cell Malignancies

Victoria Walker, PhD, Nicolas E S Guisot, PhD, Stuart Best, PhD, Fatima Talab, PhD, Catherine L Lucas, PhD, Julienne Refuerzo, Mathew Calder, Lauren Proctor, Melanie Muller, PhD, Kelvin Ho, PhD, Rose Chappell, Juliette Emmerich, PhD, Shona Harmon, PhD, Matilda Bingham, PhD, Mary-Ann Campbell, PhD, Richard Armer, PhD

Blood (2015) 126 (23): 4848.

https://doi.org/10.1182/blood.V126.23.4848.4848

Published: 2015

Journal Articles

A Single Amino Acid Substitution (I18V) in the Gla Domain of Activated Protein C Markedly Impairs Ability of PE and GlyCer to Enhance Anticoagulant Activity

Jennifer Johnson, BSc, Fionnuala Ni Ainle, MD, Shona Harmon, PhD, James S O’Donnell, MD, PhD, Roger JS Preston, PhD

Blood (2008) 112 (11): 3071.

https://doi.org/10.1182/blood.V112.11.3071.3071

Published: 2008

Journal Articles

Platelet Factor 4 Mediates Activated Protein C Resistance by Impairment of Protein S Cofactor Enhancement

Roger JS Preston, PhD, Jennifer A Johnson, BSc, Fionnuala Ni Ainle, MD, Shona Harmon, PhD, Owen P. Smith, MD, Barry White, MD, James S O’Donnell, MD, PhD

Blood (2008) 112 (11): 20.

https://doi.org/10.1182/blood.V112.11.20.20

Published: 2008

Journal Articles

Enhancement of the Anticoagulant Properties of Protamine Sulphate by Activated Protein C

Fionnuala Ni Ainle, MD, Roger JS Preston, PhD, Vince P Jenkins, PhD, Jennifer A Johnson, BSc, Shona Harmon, PhD, O. Smith, Barry White, MD, James S O’Donnell, MD, PhD

Blood (2008) 112 (11): 22.

https://doi.org/10.1182/blood.V112.11.22.22

Published: 2008

Journal Articles

Dissociation of Activated Protein C Functions by Elimination of Protein S Cofactor Enhancement

Roger JS Preston, PhD, Shona Harmon, PhD, Fionnuala B Ni Ainle, MD, Jennifer A Johnson, BSc, Moya Cunningham, MD, O. Smith, Barry White, MD, James S O’Donnell, MD, PhD

Blood (2008) 112 (11): 21.

https://doi.org/10.1182/blood.V112.11.21.21

Published: 2008

NARROW

Development of REDX05194, a Novel, Potent and Selective Inhibitor of Bruton's Tyrosine Kinase (BTK) As a Potential Treatment for B-Cell Malignancies

A Single Amino Acid Substitution (I18V) in the Gla Domain of Activated Protein C Markedly Impairs Ability of PE and GlyCer to Enhance Anticoagulant Activity

Platelet Factor 4 Mediates Activated Protein C Resistance by Impairment of Protein S Cofactor Enhancement

Enhancement of the Anticoagulant Properties of Protamine Sulphate by Activated Protein C

Dissociation of Activated Protein C Functions by Elimination of Protein S Cofactor Enhancement

Email alerts

ASH Publications

American Society of Hematology

Development of REDX05194, a Novel, Potent and Selective Inhibitor of Bruton's Tyrosine Kinase (BTK) As a Potential Treatment for B-Cell Malignancies

A Single Amino Acid Substitution (I18V) in the Gla Domain of Activated Protein C Markedly Impairs Ability of PE and GlyCer to Enhance Anticoagulant Activity

Platelet Factor 4 Mediates Activated Protein C Resistance by Impairment of Protein S Cofactor Enhancement

Enhancement of the Anticoagulant Properties of Protamine Sulphate by Activated Protein C

Dissociation of Activated Protein C Functions by Elimination of Protein S Cofactor Enhancement

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only